In October 2022, Dr Klaus Schwamborn took over as Head of Vaccine Development in the Translational Project Management Office (TPMO) at DZIF. The TPMO supports product development, from active
Approximately 300 million people worldwide are chronically infected with the hepatitis B virus (HBV) and at high risk of developing liver cirrhosis or hepatocellular carcinoma. Consequently, there is
Hepatitis B virus (HBV) infections remain a major global health problem – according to the World Health Organization (WHO) there are around 300 million HBV carriers worldwide. Current treatments
